Viewing Study NCT05008666


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-01-08 @ 9:38 PM
Study NCT ID: NCT05008666
Status: UNKNOWN
Last Update Posted: 2021-08-17
First Post: 2021-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module